The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals
Abstract
Fragile X syndrome is a frequent cause of mental retardation resulting from the absence of FMRP, the protein encoded by the FMR1 gene. FMRP is an RNA-binding protein of unknown function which is associated with ribosomes. To gain insight into FMRP function, we performed immunolocalization analysis of FMRP truncation and fusion constructs which revealed a nuclear localization signal (NLS) in the amino terminus of FMRP as well as a nuclear export signal (NES) encoded by exon 14. A 17 amino acid peptide containing the FMRP NES, which closely resembles the NES motifs recently described for HIV-1 Rev and PKI, is sufficient to direct nuclear export of a microinjected protein conjugate. Sucrose gradient analysis shows that FMRP ribosome association is RNA-dependent and FMRP is found in ribonucleoprotein (RNP) particles following EDTA treatment. These data are consistent with nascent FMRP entering the nucleus to assemble into mRNP particles prior to export back into the cytoplasm and suggests that fragile X syndrome may result from altered translation of transcripts which normally bind to FMRP.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FMRP is an RNA-binding protein, and, despite its clear shuttling from the nucleus to the cytoplasm (59,60), only the cytoplasmic function of FMRP has been well characterized.”
From Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics (2012) · cites this paper as [59]
Citations
Cites
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
Instability of a 550-Base Pair DNA Segment and Abnormal Methylation in Fragile X Syndrome
Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boué, J., Bertheas, M. F., & Mandel, J. L. (1991) · Science · doi:10.1126/science.252.5009.1097 · Cited by 1,499
Identification of a signal for rapid export of proteins from the nucleus
Wen, W., Meinkotht, J. L., Tsien, R. Y., & Taylor, S. S. (1995) · Cell · doi:10.1016/0092-8674(95)90435-2 · Cited by 1,190
Fischer, U., Huber, J., Boelens, W. C., Mattaj, I. W., & Lührmann, R. (1995) · Cell · doi:10.1016/0092-8674(95)90436-0 · Cited by 1,140
Görlich, D., & Mattaj, I. W. (1996) · Science · doi:10.1126/science.271.5255.1513 · Cited by 1,081
Devys, D., Lutz, Y., Rouyer, N., Bellocq, J., & Mandel, J. (1993) · Nature Genetics · doi:10.1038/ng0893-335 · Cited by 781
FMR1 Protein: Conserved RNP Family Domains and Selective RNA Binding
Ashley, C. T., Wilkinson, K. D., Reines, D., & Warren, S. T. (1993) · Science · doi:10.1126/science.7692601 · Cited by 752
DNA methylation represses FMR-1 transcription in fragile X syndrome
Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D., & Warren, S. T. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.6.397 · Cited by 680
The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.
Siomi, H., Siomi, M. C., Nussbaum, R. L., & Dreyfuss, G. (1993) · Cell · doi:10.1016/0092-8674(93)90420-u · Cited by 641
Cited by
Sorted by citations
Items 201–300 of 387
FMRP Interacts with C/D Box snoRNA in the Nucleus and Regulates Ribosomal RNA Methylation
D’Souza, M. N., Gowda, N. K. C., Tiwari, V., Babu, R. O., Anand, P., Dastidar, S. G., Singh, R., James, O. G., Selvaraj, B. T., Pal, R., et al. (2018) · iScience · doi:10.1016/j.isci.2018.11.007 · Cited by 34
Fragile X syndrome and model organisms: identifying potential routes of therapeutic intervention
Bhogal, B., & Jongens, T. A. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.002006 · Cited by 36
Schrier, M., Severijnen, L., Reis, S. A., Rife, M. F., VANTPADJE, S., VANCAPPELLEN, G., Oostra, B. A., & Willemsen, R. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.039 · Cited by 34
Jeon, S. J., Seo, J. E., Yang, S., Choi, J. W., Wells, D. G., Shin, C. Y., & Ko, K. H. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-17 · Cited by 32
Limbic Epileptogenesis in a Mouse Model of Fragile X Syndrome
Qiu, L.-F., Lu, T., Hu, X.-L., Yi, Y., Liao, W., & Xiong, Z. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn163 · Cited by 33
Liu, T., Wan, R.-P., Tang, L.-J., Liu, S., Li, H., Zhao, Q.-H., Liao, W., Sun, X., Yi, Y., & Long, Y. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8770-1 · Cited by 34
Human pluripotent stem cell models of Fragile X syndrome
Bhattacharyya, A., & Zhao, X. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.11.011 · Cited by 33
Fragile X syndrome neurobiology translates into rational therapy
Braat, S., & Kooy, R. F. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.01.013 · Cited by 35
Lü, P., Chen, X., Feng, Y., Zeng, Q., Jiang, C., Zhu, X., Fan, G., & Xue, Z. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-0194-6 · Cited by 32
Pathogenesis of Börjeson-Forssman-Lehmann syndrome: Insights from PHF6 function
Jahani‐Asl, A., Cheng, C., Zhang, C., & Bonni, A. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.09.011 · Cited by 37
Zalfa, F., & Bagni, C. (2004) · Current Issues in Molecular Biology · doi:10.21775/cimb.006.073 · Cited by 33
Pharmacotherapy for Fragile X Syndrome: Progress to Date
Davenport, M. H., Schaefer, T. L., Friedmann, K., Fitzpatrick, S. E., & Erickson, C. A. (2016) · Drugs · doi:10.1007/s40265-016-0542-y · Cited by 33
Fragile X syndrome: from gene discovery to therapy
Heulens, I. (2010) · Frontiers in bioscience · doi:10.2741/3785 · Cited by 32
Egeo, A., Mazzocco, M., Sotgia, F., Arrigo, P., Oliva, R., Bergoñón, S., Nižetić, D., Rasore-Quartino, A., & Scartezzini, P. (1998) · Human Genetics · doi:10.1007/s004390050693 · Cited by 30
Zhang, W., Cheng, Y., Li, Y., Chen, Z., Jin, P., & Chen, D. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu241 · Cited by 29
RNA Targets of the Fragile X Protein
Kaytor, M. D., & Orr, H. T. (2001) · Cell · doi:10.1016/s0092-8674(01)00590-6 · Cited by 29
Mouse models of fragile X-related disorders
Willemsen, R., & Kooy, R. F. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049485 · Cited by 30
Nadano, D., Ishihara, G., Aoki, C., Yoshinaka, T., Irie, S., & Sato, T. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb01017.x · Cited by 28
Decoding m6A mRNA methylation by reader proteins in liver diseases
Sun, L., Chen, X., Zhu, S., Wang, J., Diao, S., Liu, J., Xu, J., Li, X., Sun, Y.-Y., Huang, C., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.054 · Cited by 28
FMRP-Driven Neuropathology in Autistic Spectrum Disorder and Alzheimer's disease: A Losing Game
Bleuzé, L., Triaca, V., & Borreca, A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.699613 · Cited by 28
Genetic effects on human cognition: lessons from the study of mental retardation syndromes
Nokelainen, P. T. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.3.287 · Cited by 27
Experimental identification of microRNA targets on the 3′ untranslated region of human FMR1 gene
Yi, Y., Sun, X., Qin, J.-M., Zhao, Q.-H., Liao, W., & Long, Y. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.04.022 · Cited by 26
Handling FMRP and its molecular partners: Structural insights into Fragile X Syndrome
D’Annessa, I., Cicconardi, F., & Marino, D. D. (2018) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2018.07.001 · Cited by 31
Nuclear proteins and cell death in inherited neuromuscular disease
Morris, G. E. (2000) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00131-5 · Cited by 26
Molecular phenotype of Fragile X syndrome: FMRP, FXRPs, and protein targets
Kaufmann, W. E., Cohen, S., Sun, H., & Ho, G. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10066 · Cited by 25
Huot, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.24.2803 · Cited by 25
Liu, W., Seto, J., Sibille, E. L., & Tóth, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4083-4093.2003 · Cited by 25
Dampened dopamine‐mediated neuromodulation in prefrontal cortex of fragile X mice
Paul, K., Venkitaramani, D. V., & Cox, C. L. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.241067 · Cited by 25
Characterization ofFxr1inDanio rerio; a simple vertebrate model to study costamere development
Engels, B., Padje, S. V. ‘., Blonden, L., Severijnen, L.-A. W. F. M., Oostra, B. A., & Willemsen, R. (2004) · Journal of Experimental Biology · doi:10.1242/jeb.01146 · Cited by 24
Salat, U., Bardoni, B., Wöhrle, D., & Steinbach, P. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.11.842 · Cited by 24
Fragile X syndrome: An aging perspective
Schneider, A., Ligsay, A., & Hagerman, R. J. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1129 · Cited by 23
Jeon, S. J., Kim, J., Kim, K. C., Han, S. M., Go, H. S., Seo, J. E., Choi, C. S., Ryu, J. H., Shin, C. Y., & Song, M. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-0014-9 · Cited by 23
The X chromosome and fragile X mental retardation
Oostra, B. A., & Willemsen, R. (2002) · Cytogenetic and Genome Research · doi:10.1159/000071602 · Cited by 24
Cloutier, J.-F., Castonguay, A., O'Connor, T. R., & Drouin, R. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4371 · Cited by 23
Pellerin, D., Lortie, A., & Corbin, F. (2017) · Platelets · doi:10.1080/09537104.2017.1317733 · Cited by 25
Grabczyk, E., Kumari, D., & Usdin, K. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00572-x · Cited by 22
New insights into Fragile X syndrome
Pozdnyakova, I., & Regan, L. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2004.04527.x · Cited by 22
Prenatal diagnosis of fragile X syndrome and the risk of expansion of a premutation
Kallinen, J., Heinonen, S. T., Mannermaa, A., & Ryynänen, M. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.580204.x · Cited by 22
Identification of Messenger RNAs and MicroRNAs Associated With Fragile X Mental Retardation Protein
Duan, R., & Jin, P. (2006) · Humana Press eBooks · doi:10.1385/1-59745-123-1:267 · Cited by 22
Animal Model for Fragile X Syndrome
Oostra, B. A., & Hoogeveen, A. T. (1997) · Annals of Medicine · doi:10.3109/07853899709007483 · Cited by 21
The Fragile X Syndrome and Other Fragile Site Disorders
Kooy, R. F., Oostra, B. A., & Willems, P. J. (1998) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69680-3_1 · Cited by 22
Positive feedback regulation of Akt‐FMRP pathway protects neurons from cell death
Jeon, S., Han, S., Yang, S., Choi, J. W., Kwon, K. J., Park, S. H., Kim, H. Y., Cheong, J. H., Ryu, J. H., Ko, K. H., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07886.x · Cited by 22
Kumari, D., Gazy, I., & Usdin, K. (2019) · Brain Sciences · doi:10.3390/brainsci9020039 · Cited by 21
Hoogeveen, A. T., & Oostra, B. A. (1997) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005392319533 · Cited by 23
Turimella, S. L., Bedner, P., Skubal, M., Vangoor, V. R., Kaczmarczyk, L., Karl, K. A., Zoidl, G., Gieselmann, V., Seifert, G., Steinhäuser, C., et al. (2014) · Hippocampus · doi:10.1002/hipo.22399 · Cited by 20
Mechanism of Repeat-Associated MicroRNAs in Fragile X Syndrome
Kelley, K. M. M., Chang, S.-J. E., & Lin, S.-L. (2012) · Neural Plasticity · doi:10.1155/2012/104796 · Cited by 20
Increasing our understanding of human cognition through the study of fragile X syndrome
Cook, D., Nuro, E., & Murai, K. K. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22096 · Cited by 22
Lost Once, the Fragile X Mental Retardation Protein is Now Back onto Brain Polyribosomes
Davidovic, L., Huot, M., & Khandjian, É. W. (2005) · RNA Biology · doi:10.4161/rna.2.1.1368 · Cited by 20
Fragile X Syndrome: An Update on Developing Treatment Modalities
Healy, A. M., Rush, R., & Ocain, T. D. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200019z · Cited by 19
A study of the ultrastructure of Fragile-X-related proteins
Sjekloća, L., Konarev, P. V., Eccleston, J. F., Taylor, I. A., Svergun, D. I., & Pastore, A. (2009) · Biochemical Journal · doi:10.1042/bj20082197 · Cited by 19
A fragile X mental retardation-like gene in a cnidarian
Guduric‐Fuchs, J., Möhrlen, F., Frohme, M., & Uri Frank, A. (2004) · Gene · doi:10.1016/j.gene.2004.10.007 · Cited by 19
Expression of fragile X mental retardation protein and Fmr1 mRNA during folliculogenesis in the rat
Ferder, I. C., Parborell, F., Sundblad, V., Chiauzzi, V. A., Gómez, K. A., Charreau, E. H., Tesone, M., & Daín, L. (2013) · Reproduction · doi:10.1530/rep-12-0305 · Cited by 18
Splice form‐dependent regulation of axonal arbor complexity by FMRP
Zimmer, S. E., Doll, S. G., Garcia, A. D. R., & Akins, M. R. (2016) · Developmental Neurobiology · doi:10.1002/dneu.22453 · Cited by 17
Castrén, M. L., Haapasalo, A., Oostra, B. A., & Ċastrén, E. (2001) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007117211490 · Cited by 18
Reduced RNA expression of the FMR1 gene in women with low (CGGn<26) repeats
Wang, Q., Barad, D. H., Darmon, S. K., Kushnir, V. A., Wu, Y.-G., Lazzaroni-Tealdi, E., Zhang, L., Albertini, D. F., & Gleicher, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209309 · Cited by 18
FMRP ribonucleoprotein complexes and RNA homeostasis
Suardi, G. A. M., & Haddad, L. A. (2020) · Advances in genetics · doi:10.1016/bs.adgen.2020.01.001 · Cited by 18
Fragile X mental retardation protein in plasticity and disease
Todd, P. K., & Malter, J. S. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10453 · Cited by 17
Sheikh, O., & Yokota, T. (2021) · BioDrugs · doi:10.1007/s40259-021-00486-7 · Cited by 17
Gareau, C., Martel, D., Coudert, L., Mellaoui, S., & Mazrouï, R. (2012) · Biology Open · doi:10.1242/bio.20123012 · Cited by 15
microRNAs and Fragile X Syndrome
Lin, S.-L. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22671-2_7 · Cited by 17
FMRP and its target RNAs: fishing for the specificity
Veneri, M., Zalfa, F., & Bagni, C. (2004) · Neuroreport · doi:10.1097/00001756-200411150-00002 · Cited by 16
Mtango, N. R., Potireddy, S., & Latham, K. E. (2008) · Molecular Reproduction and Development · doi:10.1002/mrd.20950 · Cited by 16
A non-canonical start codon in the Drosophila fragile X gene yields two functional isoforms
Beerman, R. W., & Jongens, T. A. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.029 · Cited by 16
Signals from the X: signal transduction and X‐linked mental retardation
Barnes, A. P., & Milgram, S. L. (2002) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(02)00016-3 · Cited by 15
Šmidák, R., Sialana, F. J., Kristofova, M., Stojanovic, T., Rajcic, D., Maliković, J., Feyissa, D. D., Korz, V., Hoeger, H., Wackerlig, J., et al. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00384 · Cited by 15
Liu, M., Hsu, T.-Y., Chen, J., & Yang, C. (1998) · Virology · doi:10.1006/viro.1998.9228 · Cited by 15
Kindler, S., & Monshausen, M. (2002) · Molecular Neurobiology · doi:10.1385/mn:25:2:149 · Cited by 15
Kratovac, S., & Corbin, J. G. (2013) · Brain Research · doi:10.1016/j.brainres.2013.08.052 · Cited by 14
Isolation and Identification of Gene-Specific MicroRNAs
Lin, S.-L., Chang, D. C., & Ying, S. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7601-0_14 · Cited by 14
Canadian Association of Neurosciences Review: Polyglutamine Expansion Neurodegenerative Diseases
Truant, R., Raymond, L. A., Xia, J., Pinchev, D., Burtnik, A., & Atwal, R. S. (2006) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710000514x · Cited by 13
Pietropaolo, S., & Subashi, E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.014 · Cited by 12
Modelling Protein Synthesis as A Biomarker in Fragile X Syndrome Patient-Derived Cells
Pal, R., & Bhattacharya, A. (2019) · Brain Sciences · doi:10.3390/brainsci9030059 · Cited by 15
Identification and Characterisation of Simiate, a Novel Protein Linked to the Fragile X Syndrome
Derlig, K., Gießl, A., Brandstätter, J. H., Enz, R., & Dahlhaus, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083007 · Cited by 12
The mGluR Theory of Fragile X: From Mice to Men
Stoppel, L. J., Osterweil, E. K., & Bear, M. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804461-2.00009-3 · Cited by 9
Gene Silencing In Vitro and In Vivo Using Intronic MicroRNAs
Deng, J. H., Deng, P., Lin, S.-L., & Ying, S. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1538-5_20 · Cited by 10
Wołczyk, M., Serwa, R. A., Kominek, A., Klejman, A., Miłek, J., Chwałek, M., Turos-Korgul, L., Charzyńska, A., Dąbrowski, M., Dziembowska, M., et al. (2022) · iScience · doi:10.1016/j.isci.2023.106543 · Cited by 8
Fragile X family members have important and non-overlapping functions
Winograd, C., & Ceman, S. (2011) · BioMolecular Concepts · doi:10.1515/bmc.2011.033 · Cited by 12
Fragile X syndrome: Current insight
Dean, D. D., Muthuswamy, S., & Agarwal, S. (2016) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2016.01.005 · Cited by 11
Budimirovic, D. B., & Duy, P. Q. (2015) · Engrami · doi:10.5937/engrami1504005b · Cited by 9
Kieffer, F., Hilal, F. F., Gay, A.-S., Debayle, D., Pronot, M., Poupon, G., Lacagne, I., Bardoni, B., Martin, S., & Gwizdek, C. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.954087 · Cited by 9
Ledoux, N., Gauthier-Naud, W., Lavoie, O., Watters, V., Hussein, S. M. I., Adjibade, P., & Mazrouï, R. (2023) · Molecular Biology of the Cell · doi:10.1091/mbc.e22-05-0157 · Cited by 9
FMRP Interacts with RARα in Synaptic Retinoic Acid Signaling and Homeostatic Synaptic Plasticity
Park, E., Lau, A. G., Arendt, K. L., & Chen, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126579 · Cited by 11
Imaging of Molecular Dynamics Regulated by Electrical Activities in Neural Circuits and in Synapses
Fujii, R., Ichikawa, M., & Ozaki, M. (2008) · Neurosignals · doi:10.1159/000123037 · Cited by 8
Functions of the fragile X protein
Oostra, B. A. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02271-2 · Cited by 9
Progress toward therapeutic potential for AFQ056 in Fragile X syndrome
Doering, L. C., Sourial, M. M., & Cheng, C. (2013) · Journal of Experimental Pharmacology · doi:10.2147/jep.s27044 · Cited by 8
Bcl-2-associated transcription factor 1 interacts with fragile X-related protein 1
Ma, Y., Wang, C., Bin-yuan, L., LingXue, Q. I. N., Su, J., Yang, M., & He, S. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt134 · Cited by 8
Trinucleotide Repetition and Fragile X Syndrome
Warren, S. T. (1997) · Hospital Practice · doi:10.1080/21548331.1997.11443466 · Cited by 8
Gantois, I., & Kooy, R. F. (2002) · Genome biology · doi:10.1186/gb-2002-3-5-reviews1014 · Cited by 8
From wings to whiskers to stem cells: why every model matters in fragile X syndrome research
Sandoval, S. O., Méndez-Albelo, N. M., Xu, Z., & Zhao, X. (2024) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-024-09545-w · Cited by 9
Hu, L., Chen, Y., Evers, S., & Shen, Y. (2005) · PROTEOMICS · doi:10.1002/pmic.200401252 · Cited by 7
Fatimy, R. E., Tremblay, S., Dury, A. Y., Solomon, S., Koninck, P. D., Schrader, J. W., & Khandjian, É. W. (2012) · PLoS ONE · doi:10.1371/annotation/05374d07-34cf-483f-80f4-ec87374cbeb6 · Cited by 7
Carbohydrate Modifications in Antisense Oligonucleotide Therapy: New Kids on the Block
Manoharan, M., Kawasaki, A. M., Prakash, T. P., Fraser, A. S., Prhavc, M., Inamati, G. B., Casper, M. D., & Cook, P. D. (1999) · Nucleosides and Nucleotides · doi:10.1080/07328319908044838 · Cited by 7
From Discovery to Innovative Translational Approaches in 80 Years of Fragile X Syndrome Research
van der Lei, M. B., & Kooy, R. F. (2025) · Biomedicines · doi:10.3390/biomedicines13040805 · Cited by 6
Takahashi, N., Tarumi, W., Itoh, M., & Ishizuka, B. (2015) · Reproductive Sciences · doi:10.1177/1933719115589416 · Cited by 6
CMP-N-acetylneuraminic acid synthetase interacts with fragile X related protein 1
Ma, Y., Tian, S., Wang, Z., Wang, C., Chen, X., Li, W., Yang, Y., & He, S. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5438 · Cited by 6
Kulkarni, A., Lopez, D. H., & Extavour, C. G. M. (2020) · Frontiers in Ecology and Evolution · doi:10.3389/fevo.2020.00215 · Cited by 8
Gene Silencing In Vitro and In Vivo Using Intronic MicroRNAs
Lin, S.-L., & Ying, S. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7601-0_9 · Cited by 6
McCoy, M., Poliquin-Duchesneau, D., & Corbin, F. (2016) · Biochemistry and Cell Biology · doi:10.1139/bcb-2015-0131 · Cited by 7
Stem Cell Technology for (Epi)genetic Brain Disorders
Riemens, R. J. M., Soares, E. S., Esteller, M., & Delgado‐Morales, R. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_23 · Cited by 6
Kanezaki, R., Toki, T., Xu, G., Narayanan, R., & Ito, E. (2006) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.209.169 · Cited by 5
Metadata
- Authors
- Eberhart, D.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Eberhart, D.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-08-01
- Volume
- 5
- Issue
- 8
- Pages
- 1083-1091
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2106239245
- Cited by
- 390
- References
- 53
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 3 · 2023: 4 · 2022: 6 · 2021: 7 · 2020: 7 · 2019: 11 · 2018: 13 · 2017: 10 · 2016: 11 · 2015: 13 · 2014: 17 · 2013: 21 · 2012: 21
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 20521)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Keywords
- fragile X syndrome, FMRP, FMR1 gene, nuclear localization signal, nuclear export signal, ribonucleoprotein, RNA-binding proteins, ribosome association, exon 14, protein localization, translational regulation
- MeSH terms
- Amino Acid Sequence, Animals, Biological Transport, Active, Cell Nucleus, Exons, Fragile X Syndrome, Humans, Models, Biological, Molecular Sequence Data, Nerve Tissue Proteins, Recombinant Fusion Proteins, Ribonucleoproteins, Ribosomes, Transfection, RNA-Binding Proteins, COS Cells, Protein Sorting Signals, Fragile X Messenger Ribonucleoprotein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review